- Home
- SNES vs ACON Comparison
SNES vs ACON Comparison
Compare SNES & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNES | ACON |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | 11 |
| Industry | Agricultural Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 8.1M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNES | ACON |
|---|---|---|
| Price | $1.63 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 36.8K | ★ 69.3K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,000.00 | N/A |
| Revenue This Year | $29.00 | $87.22 |
| Revenue Next Year | $95.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.56 | N/A |
| 52 Week Low | $1.41 | $2.34 |
| 52 Week High | $5.99 | $12.03 |
Technical Indicators
Market Signals| Indicator | SNES | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 46.87 |
| Support Level | $1.55 | $2.98 |
| Resistance Level | $1.76 | $3.55 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 40.38 | 38.25 |
Price Performance
Historical ComparisonAbout SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.